Newsroom
CONTACTS
Media: Sunny Uberoi, 212.994.8206
Investors: Robert Anstey, 800.962.2436
Recent Press Releases
| DATE |
TITLE (click to view) |
| December 23, 2008 | Antigenics Receives NASDAQ Delisting Notice |
| November 26, 2008 | Antigenics Receives NASDAQ Delisting Notification |
| November 24, 2008 | Final Data From Phase 1 Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at the Society for Neuro-Oncology’s Annual Meeting |
| November 5, 2008 | Antigenics Reports Third Quarter 2008 Financial Results |
| November 3, 2008 | Antigenics to Present at the Rodman and Renshaw 10th Annual Healthcare Conference |
| October 31, 2008 | Antigenics to Report Third Quarter 2008 Financial Results on November 5, 2008; Conference Call to Follow |
| October 22, 2008 | Antigenics Submits Oncophage® Application for European Approval |
| September 29, 2008 | FDA Grants Permission For Export of Antigenics’ Oncophage to Russia |
| September 15, 2008 | Antigenics to Present at the UBS 2008 Global Life Sciences Conference |
| July 31, 2008 | Antigenics Reports Second Quarter 2008 Financial Results |
| |
More news releases » |
|
|
Click to download the essential documents about Antigenics.
(1 MB .zip) |
|
|
